This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Dec 4;99(1):32.

doi: 10.1186/s42506-024-00178-4.

Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt

Ahmad N Fasseeh^{1

2}, Nada Korra³, Baher Elezbawy², Amal S Sedrak^{4

5}, Mary Gamal⁵, Randa Eldessouki⁶, Mariam Eldebeiky⁵, Mohsen George⁷, Ahmed Seyam⁷, Asmaa Abourawash⁸, Ahmed Y Khalifa⁹, Mayada Shaheen¹⁰, Sherif Abaza², Zoltán Kaló^{11

12}

Affiliations

Affiliations

¹ Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
² Syreon Middle East, Alexandria, Egypt.
³ Syreon Middle East, Alexandria, Egypt. nada.korra@syreon.eu.
⁴ Department of Public Health, Cairo University, Cairo, Egypt.
⁵ Egyptian Authority for Unifed Procurement, Medical Supply and Technology Management, Cairo, Egypt.
⁶ Department of Community Health, Fayoum University, Fayoum, Egypt.
⁷ Universal Health Insurance Authority, Cairo, Egypt.
⁸ Egyptian Drug Authority, Cairo, Egypt.
⁹ World Health Organization Representative Office, Cairo, Egypt.
¹⁰ Roche, Cairo, Egypt.
¹¹ Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
¹² Syreon Research Institute, Budapest, Hungary.

PMID: 39630162
PMCID: PMC11618253
DOI: 10.1186/s42506-024-00178-4

Published Erratum

Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt

Ahmad N Fasseeh et al. J Egypt Public Health Assoc. 2024.

. 2024 Dec 4;99(1):32.

doi: 10.1186/s42506-024-00178-4.

Authors

Ahmad N Fasseeh^{1

2}, Nada Korra³, Baher Elezbawy², Amal S Sedrak^{4

5}, Mary Gamal⁵, Randa Eldessouki⁶, Mariam Eldebeiky⁵, Mohsen George⁷, Ahmed Seyam⁷, Asmaa Abourawash⁸, Ahmed Y Khalifa⁹, Mayada Shaheen¹⁰, Sherif Abaza², Zoltán Kaló^{11

12}

Affiliations

¹ Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
² Syreon Middle East, Alexandria, Egypt.
³ Syreon Middle East, Alexandria, Egypt. nada.korra@syreon.eu.
⁴ Department of Public Health, Cairo University, Cairo, Egypt.
⁵ Egyptian Authority for Unifed Procurement, Medical Supply and Technology Management, Cairo, Egypt.
⁶ Department of Community Health, Fayoum University, Fayoum, Egypt.
⁷ Universal Health Insurance Authority, Cairo, Egypt.
⁸ Egyptian Drug Authority, Cairo, Egypt.
⁹ World Health Organization Representative Office, Cairo, Egypt.
¹⁰ Roche, Cairo, Egypt.
¹¹ Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
¹² Syreon Research Institute, Budapest, Hungary.

PMID: 39630162
PMCID: PMC11618253
DOI: 10.1186/s42506-024-00178-4

No abstract available

PubMed Disclaimer

Erratum for

Framework for developing cost-effectiveness analysis threshold: the case of Egypt.
Fasseeh AN, Korra N, Elezbawy B, Sedrak AS, Gamal M, Eldessouki R, Eldebeiky M, George M, Seyam A, Abourawash A, Khalifa AY, Shaheen M, Abaza S, Kaló Z. Fasseeh AN, et al. J Egypt Public Health Assoc. 2024 Jun 3;99(1):12. doi: 10.1186/s42506-024-00159-7. J Egypt Public Health Assoc. 2024. PMID: 38825614 Free PMC article.

References

1. Fasseeh AN, et al. Framework for developing cost-effectiveness analysis threshold: the case of Egypt. J Egypt Public Health Assoc. 2024;99:12. 10.1186/s42506-024-00159-7. - PMC - PubMed

Publication types

Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
- PubMed Central
- Springer